Guided Therapeutics (GTHP) Asset Utilization Ratio (2012 - 2025)
Guided Therapeutics recorded quarterly Asset Utilization Ratio of 0.69 in Q4 2025, up 256.6% quarter-over-quarter from 0.19 in Q3 2025, and up 12825.2% year-over-year from N/an in Q4 2024.
Guided Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.69 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio rose 12825.2% year-over-year to 0.69; the TTM figure through Dec 2025 stood at 0.69 (up 12825.2% YoY), while the FY2025 annual figure was 0.57, up 12256.19% from the prior year.
- Asset Utilization Ratio came in at 0.69 for Q4 2025 at Guided Therapeutics, up from 0.19 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.69 in Q4 2025 to a low of 0.0 in Q1 2025.
- A 5-year average of 0.08 and a median of 0.04 in 2022 frame the typical range for Asset Utilization Ratio.
- On a YoY basis, Asset Utilization Ratio climbed as much as 12825.2% in 2025 and fell as far as 98.36% in 2025.
- Guided Therapeutics' Asset Utilization Ratio stood at 0.04 in 2021, then plunged by 91.61% to 0.0 in 2022, then soared by 1438.52% to 0.06 in 2023, then plunged by 90.36% to 0.01 in 2024, then surged by 12825.2% to 0.69 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.69, 0.19, and 0.12 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.39 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.47 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.65 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.74 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.57 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.56 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 0.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.69 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.05 |
| Dec 31, 2020 | 0.08 |
| Sep 30, 2020 | 0.08 |
| Jun 30, 2020 | 0.03 |
| Mar 31, 2020 | 0.02 |
| Dec 31, 2019 | 0.05 |
| Sep 30, 2019 | 0.21 |
| Jun 30, 2019 | 0.19 |
| Mar 31, 2019 | 0.22 |
| Dec 31, 2018 | 0.15 |
| Sep 30, 2018 | 0.27 |
| Jun 30, 2018 | 0.32 |
| Mar 31, 2018 | 0.50 |
| Dec 31, 2017 | 0.38 |
| Sep 30, 2017 | -0.29 |
| Jun 30, 2017 | -0.19 |
| Mar 31, 2017 | -0.24 |
| Dec 31, 2016 | -0.21 |
| Sep 30, 2016 | 0.06 |
| Dec 31, 2015 | 0.02 |
| Sep 30, 2015 | 0.01 |
| Jun 30, 2015 | 0.02 |
| Mar 31, 2015 | 0.02 |
| Dec 31, 2014 | 0.02 |
| Sep 30, 2014 | 0.11 |
| Jun 30, 2014 | 0.14 |
| Mar 31, 2014 | 0.23 |
| Dec 31, 2013 | 0.26 |
| Sep 30, 2013 | 0.41 |
| Jun 30, 2013 | 0.52 |
| Mar 31, 2013 | 0.79 |
| Dec 31, 2012 | 0.81 |
| Sep 30, 2012 | 0.78 |
| Jun 30, 2012 | 1.08 |
| Mar 31, 2012 | 0.96 |